Sherpa Healthcare Partners | Activity | F4

Team Portfolio Raise Champions Essays

F4/Sherpa Healthcare Partners/Activity

Sherpa Healthcare Partners Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

5 investments· MAY 2025 – SEP 2026Show all

Investment

Participated in Link Cell Therapies' $30M Series A led by Johnson & Johnson Innovation.

Link Cell Therapies

Link Cell Therapies Sherpa Healthcare Partners

theventurecodex.comSEP 2026

SEP 2026

Investment

Invested in AusperBio, a drug discovery company, per PitchBook's latest-investment listing.

AusperBio

AusperBio Sherpa Healthcare Partners

pitchbook.comAUG 2026

AUG 2026

Investment

Participated in Avisi Technologies' $11M Series A led by MedVenture Partners.

Avisi Technologies

Avisi Technologies Sherpa Healthcare Partners

theventurecodex.comFEB 2026

FEB 2026

Investment

Led Spiro Medical's $67M Series A alongside Andera Partners and Omega Funds.

Spiro Medical

Spiro Medical Sherpa Healthcare Partners

theventurecodex.comJAN 2026

JAN 2026

Investment

Participated in PAQ Therapeutics' $39M Series B led by Bayland Capital and MRL Ventures Fund.

PAQ Therapeutics

PAQ Therapeutics Sherpa Healthcare Partners

theventurecodex.comMAY 2025

MAY 2025

Team Change

Appointed former Axonics CEO Raymond W. Cohen as Venture Partner.

Raymond W. Cohen joined as Venture Partner

Sherpa Healthcare Partners

venturecapitaljournal.comJAN 6, 2025

JAN 6, 2025

Exit

Portfolio company Axonics was acquired by Boston Scientific in a $3.7B transaction.

Axonics

Axonics Sherpa Healthcare Partners

linkedin.comNOV 2024

NOV 2024